Improvement in patient-reported outcomes after lung transplantation is not impacted by the use of extracorporeal membrane oxygenation as a bridge to transplantation

• Published in: The Journal of thoracic and cardiovascular surgery Vol. 156; no. 1; pp. 440 - 448.e2
• Main Authors: Kolaitis, Nicholas A., Soong, Allison, Shrestha, Pavan, Zhuo, Hanjing, Neuhaus, John, Katz, Patti P., Greenland, John R., Golden, Jeffrey, Leard, Lorriana E., Shah, Rupal J., Hays, Steven R., Kukreja, Jasleen, Kleinhenz, Mary Ellen, Blanc, Paul D., Singer, Jonathan P.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.07.2018
• Subjects: ECMO; extracorporeal membrane oxygenation; health-related quality of live; HRQL; HRQoL; lung transplantation; QOL; quality of life; ECMO; HRQL; CI; SF12-MCS; SF12-PCS; QOL; MCID; GDS; HRQoL; lung transplantation; health-related quality of live; extracorporeal membrane oxygenation; FEV1; EQ5D; quality of life; 6MWD; AQ20R; LAS

Extracorporeal membrane oxygenation (ECMO) is increasingly used as a bridge to lung transplantation. The impact of preoperative ECMO on health-related quality of life (HRQL) and depressive symptoms after lung transplantation remains unknown, however. In a single-center prospective cohort study, we a...